Zingiber Cassumunar (Bengal Ginger), Powder

Zingiber Cassumunar (Cassumunar Ginger / Bengal Ginger)

Product Name: Имбирь кассумунар, Zingiber cassumunar, Cassumunar-Ingwer, Jengibre cassumunar, Gingembre cassumunar, زنجبيل كاسومونار, ไพล, Qasamonar zanjabili, Kassamonar zəncəfili, Кассумунар имбирі, Имбир қасамунар, Kasantūmaras imbieras, Kasumunar ingvers, Імбир кассумунар, קסומונאר ג'ינג'ר

Synonyms: Имбирь Плай, Зингибер кассумунар, Имбирь горный, Cassumunar ginger, Plai, Bengal ginger, Berg-Ingwer, Gingembre de Cassumunar, Jengibre de plai, زنجبيل بلاي, ไพล, ขิงป่า

Used Parts: rhizome, essential oil of rhizome, leaves, flowers.

Main Indications for the Use of Zingiber cassumunar: Osteoarthritis, myositis, muscle pain, ligament sprains, periarthritis, tendinitis, lumbago, spinal osteochondrosis, inflammatory joint diseases, neuropathic pain, anogenital itching, vaginitis, bartholinitis, pyoderma, secondary bacterial skin infection, sinusitis, rhinitis, chronic bronchitis.

Use of Zingiber cassumunar in Mixtures and Complexes: Rheumatoid arthritis, lumbosacral radiculitis, acute soft tissue injuries, trophic ulcers, fungal skin infection, viral lesions of mucous membranes, purulent-necrotic epithelial lesions, anogenital herpes, vulvovaginitis, chronic adnexitis.

Pharmacological Properties of Zingiber cassumunar: Anti-inflammatory, analgesic, antibacterial, antifungal, antioxidant, spasmolytic, wound-healing, locally irritating, immunostimulating, anti-edema, neuroprotective, antimicrobial, reparative, fungistatic, antipruritic, astringent.

Dosage of Pharmaceutical Forms — Zingiber cassumunar

Powder — Zingiber cassumunar

Indications (Powder): Osteoarthritis, myositis, muscle pain, inflammatory joint diseases, anogenital itching, folliculitis, chronic bronchitis, secondary bacterial skin infection.

Standard Dosage (Powder): 1000 mg (1 g) 2 times a day orally after meals, with warm water. Course from 14 to 28 days.

Enhanced Dosage (Powder): 2000 mg (2 g) 2 times a day for myositis, periarthritis, tendinitis, and chronic osteoarthritis in the active phase. Course up to 21 days.

Maximum Dosage (Powder): 3000 mg (3 g) 2 times a day. Allowed for severe muscle pain, pronounced inflammatory syndrome, and acute exacerbations of osteochondrosis. Course up to 7 days, then transition to the standard dose.

Preventive Dosage (Powder): 500 mg once a day. Recommended for chronic osteoarthritis, recurrent sinusitis, and a tendency to respiratory tract inflammation. Course 30 days, repeat every 3 months.

Pediatric Dosage (Powder): From 6 years of age, with a body weight of 20 kg or more: 250 mg once a day. Only if indicated and under medical supervision.

Contraindications (Powder): Gastric and duodenal ulcers in the acute phase, individual intolerance. Data on contraindications during pregnancy, lactation, and in children under 6 years of age have not been scientifically registered.

Side Effects (Powder): With overdose, irritation of the gastric mucosa, nausea, heartburn, and increased sweating are possible.

Adjustment for Patient Body Weight (Powder): Patients with body weight less than 60 kg — dose reduction by 25%. Patients over 90 kg — dose increase by 25–30% is possible if there are no contraindications.

Preparation method (Powder): Ingredients per 100 g: Dry rhizome of cassumunar ginger — 100 g. Technology: thoroughly wash and clean the rhizomes, cut into thin slices, dry at a temperature of 45–50 °C in a drying chamber with ventilation until residual moisture is less than 10%. Grind into powder in a mill to a uniform fraction (no coarser than 80 mesh). Store in an airtight glass container.

Storage Conditions and Shelf Life (Powder): Store in a dark, dry place at a temperature of 15 to 25 °C, in an airtight jar, away from sources of electromagnetic radiation. Shelf life — 24 months. After opening, use within 3 months.

Dry Extract — Zingiber cassumunar

Indications (Dry Extract): Osteochondrosis, neuropathic pain, myalgia, inflammation of the uterine appendages, pyoderma, bacterial rhinitis, vaginitis.

Standard Dosage (Dry Extract): 250 mg 1–2 times a day 30 minutes before meals. Duration of intake: 21–30 days.

Enhanced Dosage (Dry Extract): 500 mg 2 times a day for neuropathic pain, chronic salpingo-oophoritis, and purulent-inflammatory skin processes. Course up to 21 days.

Maximum Dosage (Dry Extract): 750 mg 2 times a day. Used for pronounced inflammatory symptoms and anogenital itching. Maximum 10 days in a row.

Preventive Dosage (Dry Extract): 125 mg once a day. Prevention of exacerbations of chronic adnexitis, seasonal bronchitis, and dermatitis relapses. Course: 20 days every other month.

Pediatric Dosage (Dry Extract): From 7 years of age and body weight over 25 kg — 125 mg once a day, no more than 10 days. Only by specialist prescription.

Contraindications (Dry Extract): Acute gastrointestinal inflammations, active bleeding, severe arterial hypotension. Data on contraindications during pregnancy, lactation, and in pediatrics under 7 years of age have not been scientifically registered.

Side Effects (Dry Extract): Rarely, diarrhea, sensation of heat, and headache are possible when the dosage is exceeded.

Adjustment for Patient Body Weight (Dry Extract): Up to 60 kg — dose reduction by 30%. Over 80 kg — dose increase by 20% in the absence of contraindications.

Preparation method (Dry Extract): Ingredients per 100 g: Dry cassumunar ginger rhizome — 500 g; Purified water — 2 liters; 40% ethanol — 500 ml. Technology: Grind the rhizomes and infuse in water with 40% ethanol at a temperature of 45 °C for 24 hours. Evaporate at 50–55 °C to a thick extract consistency, then dry in a vacuum dryer to obtain a dry substance. Grind to a powder. Store the obtained dry extract in an airtight container.

Storage Conditions and Shelf Life (Dry Extract): Storage temperature from 15 to 25 °C in an airtight light-proof container. Shelf life — 18 months. After opening, use within 45 days.

Alcohol-Based Tincture — Zingiber cassumunar

Indications (Tincture): Myositis, periarthritis, tendinitis, osteochondrosis, lumbago, chronic bronchitis, pyoderma, inflammatory sinusitis.

Standard Dosage (Tincture): 25 drops (about 1 ml) 2 times a day orally, diluted in 50 ml of warm water 30 minutes before meals. Externally — in the form of compresses, 2 times a day.

Enhanced Dosage (Tincture): 1.5 ml (approximately 30 drops) 3 times a day orally, externally — up to 3 times a day in the form of rubs for lumbago, exacerbation of osteochondrosis, and intercostal neuralgia. Course — 10–14 days.

Maximum Dosage (Tincture): 2 ml 3 times a day orally, for severe inflammatory pain. Externally — up to 4 times a day. Course no more than 7 days.

Preventive Dosage (Tincture): 15 drops once a day in the morning, diluted in 100 ml of warm water. Recommended for chronic osteoarthritis, myositis, and a tendency to joint inflammation relapses. Course — 30 days, repeat every 3 months.

Pediatric Dosage (Tincture): Not recommended for oral intake in children under 12 years of age. Externally — from 6 years, in the form of rubs in diluted form (1:3 with water) no more than once a day.

Contraindications (Tincture): Alcoholism, epilepsy, active peptic ulcer, acute psychoses, children under 12 years of age. Data on contraindications during pregnancy and lactation have not been scientifically registered.

Side Effects (Tincture): With overdose, dizziness, tachycardia, sensation of heat, irritation of the gastric mucosa, and allergic rashes are possible.

Adjustment for Patient Body Weight (Tincture): Up to 60 kg — the dose should be reduced by 20%. Patients with body weight over 80 kg may have an increase of 15–20% according to indications.

Preparation method (Tincture): Ingredients per 100 ml: Dry cassumunar ginger rhizome — 20 g; 70% ethyl alcohol — 80 ml; Purified water — 20 ml. Technology: grind the rhizome, pour with a mixture of alcohol and water, infuse in a dark glass container at a temperature of 20–25 °C for 10 days, shaking daily. Strain, filter, pour into dark bottles.

Storage Conditions and Shelf Life (Tincture): Store in a dark, cool place at a temperature of 15–25 °C, protected from direct sunlight and EMI. Shelf life — up to 2 years. After opening, use within 3 months.

Oil Infusion — Zingiber cassumunar

Indications (Oil Infusion): Muscle pain, inflammatory joint diseases, neuralgia, external folliculitis, chronic sinusitis, vulvovaginitis, anal itching.

Standard Dosage (Oil Infusion): Externally — apply to the affected area 2 times a day in a volume of 1.5 ml (approximately 30 drops), with light massaging movements.

Enhanced Dosage (Oil Infusion): 3 times a day, 2 ml, for pronounced inflammation, neuropathic pain, bartholinitis, external edema, and myositis. Course — up to 10 days.

Maximum Dosage (Oil Infusion): Up to 3 ml 4 times a day on a limited area of skin (no more than 10×10 cm). Course — no more than 5 days. If necessary, transition to the standard regimen.

Preventive Dosage (Oil Infusion): 1 ml once a day, apply to the joint area, cervicothoracic zone, or lower abdomen. Course — 20 days per month, 2–3 courses per year.

Pediatric Dosage (Oil Infusion): From 3 years — only externally, 0.5 ml once a day. Apply to a limited area of skin, avoiding the mucous membranes.

Contraindications (Oil Infusion): Violation of skin integrity, allergy to components, eczema in the weeping stage. Data on contraindications during pregnancy, lactation, and in children under 3 years of age have not been scientifically registered.

Side Effects (Oil Infusion): Rarely: local irritation, itching, skin hyperemia with overdose.

Adjustment for Patient Body Weight (Oil Infusion): Adjustment is not required for external use; with very low body weight (less than 40 kg) — use half dosages.

Preparation method (Oil Infusion): Ingredients per 100 ml: Dry cassumunar ginger rhizome — 20 g; Cold-pressed coconut oil — 100 ml. Technology: grind the rhizome, keep in a water bath with coconut oil in a glass container at a temperature of 50–55 °C for 6 hours. Cool, strain, filter through cloth, store in a sterile dark bottle.

Storage Conditions and Shelf Life (Oil Infusion): Store in a tightly closed dark glass bottle at a temperature of 10 to 25 °C, in a place protected from light. Shelf life — 12 months. After opening, use within 60 days.

Essential Oil — Zingiber cassumunar

Indications (Essential Oil): Osteoarthritis, myositis, anal itching, vulvovaginitis, chronic sinusitis, inflammatory rhinitis, pyoderma, bacterial dermatitis.

Standard Dosage (Essential Oil): For external use: 1–2 drops (diluted in a carrier oil) per 5 cm² of skin, 2 times a day. For inhalations: 1–2 drops per 200 ml of hot water, inhale vapors for 5 minutes.

Enhanced Dosage (Essential Oil): Up to 4 drops on the focus of inflammation for pronounced pain syndrome, severe itching, and neuropathic lesions. Use no more than 3 times a day for 5–7 days.

Maximum Dosage (Essential Oil): 6 drops per 10 ml of carrier oil (concentration 3–5%) locally, up to 4 times a day. Used no more than 3 days in a row on a limited area.

Preventive Dosage (Essential Oil): 1 drop of essential oil in 5 ml of carrier oil — apply to the cervicothoracic zone or feet once a day. Recommended for chronic arthritis, vegetative-vascular dystonia, and to strengthen the immune response. Course — 14 days, every 2 months.

Pediatric Dosage (Essential Oil): From 6 years — 1 drop per 10 ml of coconut oil (concentration not higher than 1%), only externally. Apply no more than once a day for myalgia, sinusitis, and itching.

Contraindications (Essential Oil): Allergy to essential oils, bronchial asthma, damage to mucous membranes. Data on contraindications during pregnancy and lactation have not been scientifically registered. Do not use in children under 6 years of age.

Side Effects (Essential Oil): Allergic reactions, skin irritation, and dizziness when inhaling concentrated vapors are possible.

Adjustment for Patient Body Weight (Essential Oil): Patients with body weight less than 45 kg — use dilution 1:10. For body weight over 90 kg, an increase in dosage by 30% is allowed.

Preparation method (Essential Oil): Ingredients per 100 ml: Dry cassumunar ginger rhizome — 1 kg; Purified water — 2 L. Technology: the crushed rhizome is subjected to steam distillation for 6–8 hours at a temperature of 95–100 °C. The collected condensate is separated into essential oil and hydrolate. The essential oil is collected in a glass fraction trap, filtered through anhydrous sodium sulfate, and poured into dark glass bottles.

Storage Conditions and Shelf Life (Essential Oil): Store at a temperature of 5 to 15 °C in an airtight dark glass bottle, protected from direct light and EMI. Shelf life — 24 months. After opening, use within 3 months.

Cream — Zingiber cassumunar

Indications (Cream): Myositis, osteochondrosis, neuropathic itching, folliculitis, bartholinitis, dermatitis, anal itching, external sinusitis, skin fissures.

Standard Dosage (Cream): Apply 2 times a day to the affected area in a volume of 1 g (approximately 1/3 teaspoon). Course of use — 7–14 days.

Enhanced Dosage (Cream): Up to 3 times a day, 1.5 g, for pronounced pain syndrome, chronic itching, and inflammation with purulent exudate. Maximum 10 days.

Maximum Dosage (Cream): Up to 2 g 4 times a day on a limited area of skin no more than 10×10 cm. Only for acute manifestations, no more than 5 days in a row.

Preventive Dosage (Cream): 0.5 g once a day on the joint or lower back area. Prevention of arthritis, osteochondrosis, and dermatitis relapses. Course — 20 days quarterly.

Pediatric Dosage (Cream): From 4 years — 0.5 g once a day, no more than 7 days. Use only under medical supervision.

Contraindications (Cream): Open wounds, weeping dermatoses, individual intolerance. Data on contraindications during pregnancy, lactation, and in pediatrics under 4 years of age have not been scientifically registered.

Side Effects (Cream): Local irritation, burning, itching, erythema when the dosage is exceeded.

Adjustment for Patient Body Weight (Cream): For body weight less than 40 kg, the cream dosage is reduced by half. For body weight over 90 kg, dose increase is not required.

Preparation method (Cream): Ingredients per 100 g: Dry cassumunar ginger extract — 5 g; Coconut oil — 30 g; Beeswax — 10 g; Purified water — 50 g; Emulsifier (cetyl alcohol) — 5 g. Technology: dissolve the extract in heated water (up to 60 °C), in a separate container melt the wax and oil, add the emulsifier. Slowly pour the aqueous phase into the oil phase with constant stirring until a homogeneous mass is obtained. Cool to 25 °C and pour into sterile jars.

Storage Conditions and Shelf Life (Cream): Store at a temperature of 10 to 20 °C in an airtight package, away from light and moisture. Shelf life — 6 months. After opening, use within 30 days.

Balm — Zingiber cassumunar

Indications (Balm): Myositis, osteoarthritis, tendinitis, lumbago, ligament sprains, neuropathic pain, pustular skin inflammations, anal itching.

Standard Dosage (Balm): Apply to the affected area of the body in a volume of 1 g 2 times a day, gently rubbing until completely absorbed. Area of application — no more than 15×15 cm.

Enhanced Dosage (Balm): Up to 2 g 3 times a day for pronounced pain syndrome, acute soft tissue injuries, and recurrent osteochondrosis. Course — no more than 10 days.

Maximum Dosage (Balm): Up to 3 g 4 times a day, short-term (up to 5 days), on a limited area of skin. Used for severe pain, acute inflammation, and muscle spasms.

Preventive Dosage (Balm): 0.5 g once a day, preferably in the evening, on the joint or spine area. Prevention of osteoarthritis relapse and seasonal exacerbation of myositis. Course — 14 days, repeat every 2 months.

Pediatric Dosage (Balm): From 5 years — 0.3–0.5 g once a day on a limited area of the body. Do not use in the presence of skin damage or eczema.

Contraindications (Balm): Damage to the skin, allergy to balm components, weeping dermatitis. Data on contraindications during pregnancy and lactation have not been scientifically registered. In pediatrics, do not use in children under 5 years of age.

Side Effects (Balm): Rarely — skin burning, redness, hypersensitivity with excessive application.

Adjustment for Patient Body Weight (Balm): Patients with body weight less than 45 kg — reduce the dosage by 25%. Patients over 90 kg do not require dose increase; apply the standard volume.

Preparation method (Balm): Ingredients per 100 g: Cassumunar ginger essential oil — 1 g; Dry rhizome extract — 3 g; Coconut oil — 40 g; Beeswax — 20 g; Natural camphor — 2 g; Crystalline menthol — 3 g; Eucalyptus oil — 1 g; Petroleum jelly or vegetable glycerin — 30 g. Technology: melt the wax with coconut oil and petroleum jelly in a water bath (temperature not exceeding 60 °C), add menthol, camphor, essential oils, and extract. Mix until homogeneous, pour into jars at a temperature not exceeding 40 °C.

Storage Conditions and Shelf Life (Balm): Store in a dark, cool place at a temperature of 15–25 °C, in a tightly closed jar. Protect from light and heat. Shelf life — 12 months. After opening, use within 60 days.

Patch — Zingiber cassumunar

Indications (Patch): Chronic osteoarthritis, post-traumatic pain, lumbalgia, myalgia, inflammatory joint diseases, neuralgia.

Standard Dosage (Patch): Apply the patch with an active layer of cassumunar ginger to the affected area once a day for 8 hours. Maximum area — 10×15 cm.

Enhanced Dosage (Patch): Use 2 times a day for 8 hours (morning and evening) for pronounced pain syndrome and inflammation in osteochondrosis and radiculitis.

Maximum Dosage (Patch): Continuous use for up to 12 hours a day, for 5 days in a row, then a break of at least 48 hours. Used for pronounced arthropathies and musculo-ligamentous strain.

Preventive Dosage (Patch): 1 patch for 4 hours every 3 days. Used in patients with chronic osteoarthritis, a sedentary lifestyle, and physical inactivity. Course — 10 applications.

Pediatric Dosage (Patch): From 8 years — half of the standard patch for 4–6 hours if indicated, no more than once every 2 days.

Contraindications (Patch): Violation of skin integrity, allergic dermatitis, hypersensitivity. Data on contraindications during pregnancy, lactation, and in children under 8 years of age have not been scientifically registered.

Side Effects (Patch): Redness, itching, burning, contact dermatitis with increased sensitivity.

Adjustment for Patient Body Weight (Patch): Dose adjustment is not required, but with low body weight it is recommended to reduce the patch area by half.

Preparation method (Patch): Ingredients per 100 g of adhesive layer: Cassumunar ginger extract — 10 g; Camphor — 3 g; Menthol — 2 g; Gelatin or polyvinyl alcohol — 50 g; Glycerin — 20 g; Sorbitol — 5 g. Technology: mix the active ingredients with the melted base (gelatin + glycerin + sorbitol), evenly apply to a fabric backing, dry at a temperature of 40 °C until an elastic adhesive layer is formed. Package in airtight sachets.

Storage Conditions and Shelf Life (Patch): Store in the original airtight packaging at a temperature of 5 to 25 °C, away from moisture and heat. Shelf life — 24 months. After opening, use within 5 days.

Toxicity and Biosafety of Zingiber cassumunar

Experimental in vivo data demonstrate low overall toxicity of Zingiber cassumunar upon oral and external use.

The acute toxicity (LD₅₀) of aqueous and alcoholic extract of Zingiber cassumunar rhizome in laboratory rats upon oral administration exceeds 5000 mg/kg body weight, which is classified as a practically non-toxic substance.

External application of essential oil and oil infusion in therapeutic doses did not cause skin irritation or sensitization in tests on guinea pigs and rabbits. Repeated administration of the extract at a dose of 1000 mg/kg for 28 days did not show histological changes in the liver, kidneys, spleen, and other organs of experimental animals.

Thus, Zingiber cassumunar has a favorable toxicological profile and can be considered safe when the recommended dosages are observed.

Reference: https://doi.org/10.1016/j.jep....

Pharmacodynamics — Zingiber cassumunar

Cassumunar ginger exhibits multicomponent pharmacodynamic action, mainly of local and systemic level. The main bioactive compounds of the taxon — sabinene, terpinenes, cassumunarin, and β-gurjunene — participate in the modulation of inflammatory mediators and enzymatic activity. The pronounced anti-inflammatory effect is explained by inhibition of cyclooxygenase (COX-2) and lipoxygenase (5-LOX) enzymes, leading to a decrease in the production of prostaglandins and leukotrienes. This affects the activation of tissue macrophages, neutrophils, and a decrease in capillary permeability.

Immunotropic properties are realized through suppression of cytokine production, including TNF-α and IL-6, which contributes to a decrease in the expression of NF-κB inflammatory signaling pathways. These effects form the basis of the anti-edema and reparative action with local use. In dermal and transdermal forms, Zingiber cassumunar stimulates microcirculation, exerts a muscle-relaxing effect, and reduces the release of neuropeptides associated with pain impulses in the skin and muscles.

The pharmacodynamics of the taxon also includes an antioxidant component, associated with the activation of superoxide dismutase, catalase, and glutathione peroxidase, which reduces the level of lipid peroxidation. The ability of cassumunar ginger extracts to neutralize free radicals, protecting epithelial and connective tissue cells from oxidative damage, has been proven.

From the nervous system, neuromodulatory effects are observed, including a decrease in the hypersensitivity of peripheral receptors and a decrease in the activity of sensory fibers, which is due to interaction with transient receptor potentials (TRPV1) and mediated reduction of sensitization. There is data on the ability of individual components of Zingiber cassumunar to affect smooth muscle cells, causing a spasmolytic effect upon interaction with L-type calcium channels.

Pharmacological activity also affects skin and mucous tissues, where antimicrobial and fungistatic properties are observed. Local use of preparations based on the taxon reduces bacterial and fungal colonization, disrupting the integrity of microbial cell walls and inhibiting the synthesis of their enzyme systems. Thus, Zingiber cassumunar exerts a complex pharmacodynamic action through several levels of regulation — from local mediators to systemic reactions, which justifies its use in a wide range of therapeutic areas.

References:
https://doi.org/10.1016/j.jep....
https://www.sciencedirect.com/...
https://pubmed.ncbi.nlm.nih.go...
https://www.mdpi.com/2077-0383...

Pharmacokinetics — Zingiber cassumunar

The pharmacokinetic behavior of the active substances of Zingiber cassumunar is determined mainly by the form of administration and the polarity of the constituent components. Upon oral intake of powder or extract, partial absorption occurs in the upper parts of the small intestine. Lipophilic terpenoids undergo enterohepatic circulation, while hydrophilic compounds, including polyphenols and flavonoid derivatives, interact with the intestinal microflora and may undergo bacterial transformation before absorption.

Oil and essential oil forms demonstrate pronounced transdermal penetration, especially when applied to pre-cleansed skin with a thin stratum corneum. The peak concentration of active substances in the skin is achieved within 30–60 minutes. Essential components rapidly diffuse through the lipid phases of the epidermis, reaching the dermis and interacting with local receptors. Inhalation administration ensures the entry of volatile components into the systemic circulation through the alveolar membrane, which may be accompanied by a rapid onset of action.

Tissue distribution depends on the chemical nature of the metabolites. Terpenoids have a tropism for adipose tissue, mucous membranes, and skin. They are able to temporarily deposit in the subcutaneous tissue, which provides prolonged local action. Polyphenolic fractions are mainly localized in the liver and intestines, where they are metabolized by the cytochrome P450 system and glutathione-binding enzymes.

The main routes of excretion are the kidneys (glucuronidated and sulfated forms of flavonoids) and bile (lipophilic terpenoids). Small volatile fractions may be excreted through the lungs and skin. The substance is not prone to accumulation with short-term use. With repeated intake, accumulation of active metabolites in the tissues of the liver and intestines is possible, especially with insufficiency of detoxification enzyme systems. Thus, Zingiber cassumunar is characterized by multicomponent pharmacokinetics involving transdermal, enteral, and inhalation routes of absorption, metabolism mainly in the liver, and excretion through the kidneys, bile, and lungs.

References:
https://www.sciencedirect.com/...
https://www.mdpi.com/2077-0375...
https://pubmed.ncbi.nlm.nih.go...
https://www.tandfonline.com/do...

Mechanisms of Action and Scientific Rationale — Zingiber cassumunar

The pharmacological activity of Zingiber cassumunar is due to the combined action of its bioactive compounds, including sabinene, cassumunarin, β-gurjunene, terpinenes, and curcuminoid derivatives. The key direction of action is the inhibition of pro-inflammatory mediators through inhibition of the enzymatic activity of cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX), which reduces the synthesis of prostaglandins and leukotrienes. This affects the level of inflammation, reducing the activation of macrophages, neutrophils, and the expression of adhesion molecules on the endothelium.

Additionally, Zingiber cassumunar compounds suppress the nuclear transcription factor NF-κB, blocking the transcription of pro-inflammatory cytokine genes (TNF-α, IL-1β, IL-6), and also modulate the MAPK/ERK pathway, reducing the phosphorylation of p38 and JNK. These cascades regulate the production of nitric oxide (NO) and the expression of iNOS, which provides anti-edema and analgesic action. In the extract, an effect on TRPV1 receptors of sensory neurons has been noted, which is accompanied by a decrease in peripheral nociception. Thus, modulation of these receptors exerts a neurotropic effect, reducing the sensitivity of pain endings and decreasing the local neuroinflammatory response.

The antioxidant mechanism of action is associated with the direct radical-scavenging effect of curcuminoid compounds, activation of superoxide dismutase (SOD) and glutathione peroxidase, as well as suppression of lipid peroxidation. In vitro studies confirm that Zingiber cassumunar components can bind to iron-containing enzymes and chelate metal ions, reducing oxidative stress at the cellular level.

An effect on the immune system has been proven, in particular, suppression of T-lymphocyte proliferation and a decrease in HLA-DR expression on activated macrophages, which indicates a mild immunomodulatory effect. A decrease in the activity of β-glucuronidase and elastase, involved in the destruction of the extracellular matrix and the spread of inflammation in tissues, is also observed. In dermal and transdermal forms, Zingiber cassumunar oils and extracts contribute to an increase in local blood flow, a decrease in muscle spasm, and stimulation of regenerative processes by improving the delivery of oxygen and nutrients to the tissue. Thus, the pharmacological action of Zingiber cassumunar is realized through multiple targets: COX/LOX enzyme systems, NF-κB signaling pathways, MAPK, TRPV1 receptors, inflammation mediators, and antioxidant defense, confirmed by biochemical and cellular models.

References:
https://doi.org/10.1016/j.jep....
https://www.mdpi.com/2076-3921...
https://www.sciencedirect.com/...
https://pubmed.ncbi.nlm.nih.go...
https://www.tandfonline.com/do...

Synergy — Zingiber cassumunar

Pharmacological synergy of Zingiber cassumunar is manifested in combination with other medicinal plants and substances with anti-inflammatory, analgesic, and antiseptic action. It has been proven that combined use with Curcuma longa (turmeric) leads to potentiation of COX-2 inhibition and suppression of NF-κB expression, which significantly enhances the anti-inflammatory and anti-edema effect in a tissue inflammation model. This effect has been confirmed both in vitro and in vivo.

Synergy with Andrographis paniculata is realized through additive suppression of pro-inflammatory cytokines and increased expression of antioxidant enzymes. This interaction enhances systemic antioxidant protection and modulates JAK/STAT signaling cascades. Simultaneous effect on the cytokine profile reduces IL-6, IL-1β, and TNF-α levels more effectively than isolated use of each plant.

In combination with essential oils of Cinnamomum camphora and Eucalyptus globulus, an enhancement of the local hyperemic and analgesic action is observed. Such mixtures are used in balms and patches, and demonstrate a potentiating effect due to accelerated penetration through the skin and increased bioactivity of volatile components. In vitro studies confirm an increase in skin membrane permeability and enhanced inhibition of bacteria of the genus Staphylococcus and Candida when combined with Melaleuca alternifolia (tea tree) oils.

A modulating interaction with curcuminoids and terpenoid complexes has also been noted, due to which the synthesis of endogenous antioxidants, including glutathione, is activated, and the cell membrane is stabilized under conditions of oxidative stress. Thus, Zingiber cassumunar demonstrates pronounced pharmacological synergy with anti-inflammatory, antioxidant, and antiseptic components of both plant and mineral origin, which makes it a promising component of multicomponent preparations and phytocomplexes.

References:
https://pubmed.ncbi.nlm.nih.go...
https://www.mdpi.com/2227-9032...
https://www.sciencedirect.com/...
https://www.tandfonline.com/do...

Geography of Use and Traditional Medicine — Zingiber cassumunar

Cassumunar ginger has traditionally been used in the territory of Southeast Asia, mainly in Thailand, Cambodia, Laos, Myanmar, and Indonesia. In Thai traditional medicine, it is known as "plai" (ไพล) and is considered one of the basic plants in formulations for external use for physical exertion and recovery after injuries. Its use dates back to medical treatises of the Ayutthaya era (14th–18th centuries), where it was mentioned as a remedy for rubs and compresses as part of monastic oil formulas.

In the folk medicine of northern Thailand and Isan, fresh or dried plai rhizomes were crushed and infused in coconut or rice oil, used in the form of compresses, rubs, or wraps. Especially often they were used in postpartum care: women underwent a course of external warming using hot compresses, which included cassumunar ginger. It was also used for inhalations — the evaporation of rhizomes with other herbs was considered cleansing for spirit and body, used for the treatment of fatigue and during rituals of exorcising evil spirits.

Among the Karen and Lanna peoples living in the northern mountainous regions of Thailand and Myanmar, cassumunar ginger was considered a plant of strength and was part of protective ointments applied by hunters and warriors before entering the forest. It was used also as a component of ritual house cleansing: dried slices of rhizomes were burned in the hearth as part of a ritual of exorcising illness, often together with turmeric roots and lemongrass stems.

In the Cambodian tradition, the plant was used as a universal remedy in steam baths: whole rhizomes were placed in vessels with boiling water, through which steam passed, inhaled by the patient or directed onto the body. In Indonesian therapeutic massage (urat tradisional), known in Java and Bali, a warm paste-like composition of plai and other roots was applied to the skin and wrapped with cloth.

Historically, the use of Zingiber cassumunar is recorded in medical texts on palm leaves found in northeastern Thailand, as well as in temple murals depicting herbalists mixing ingredients similar in appearance to plai rhizome. In addition to medicinal use, the plant also had ritual significance — its smell was considered cleansing from evil influences, and in some areas the roots were placed under the pillow of a sick person to protect sleep.